AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being ...

Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study.

Megan Finn was on honeymoon in Spain when she first took unwell and was brought to an acute mental health centre on her return home ...

Hospital patient, 65, dies days after being assaulted by another patient; Ana Peixoto Veiga was in hospital receiving ...